Abstract
Unlike admission hyperglycaemia, there is significant controversy surrounding whether acute glycaemic variability is associated with major adverse cardiovascular events (MACE) in patients immediately after an acute myocardial infarction (AMI). We conducted a retrospective post-hoc analysis in an AMI population and determined fluctuating glycaemia is associated with a higher risk of 3-month MACE.
Original language | English |
---|---|
Article number | 100203 |
Number of pages | 4 |
Journal | Journal of Clinical and Translational Endocrinology |
Volume | 18 |
DOIs | |
Publication status | Published - 2019 |
Open Access - Access Right Statement
© 2019 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).Keywords
- blood sugar monitoring
- cardiovascular system
- diseases
- myocardial infarction